G. N. Hortobagyi - Univ Texas MD Anderson Canc Ctr

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 18 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Estrogen Receptor Positivity: 10% Or 1%

M. Yi,L. Huo, K. B. Koenig, E. A. Mittendorf, F. Meric-Bernstam, H. M. Kuerer, I. Bedrosian, W. F. Symmans,G. N. Hortobagyi, J. R. Crow, R. R. Shah, K. K. Hunt

CANCER RESEARCH（2012）

引用0浏览0引用

Retrospective review of male breast cancer patients: analysis of tamoxifen-related side-effects

N Pemmaraju,M F Munsell,G N Hortobagyi,S H Giordano

Annals of Oncology（2012）

引用99浏览0WOS引用

Erk2 Promotes Stem Cell-Like Characteristics In Triple-Negative Breast Cancer

C. Bartholomeusz,H. Saso, A. Dadbin, K. Kazuharu,G. N. Hortobagyi

CANCER RESEARCH（2011）

引用0浏览0引用

A Randomized Phase Ill Clinical Trial Of Standard Adjuvant Endocrine Therapy Plus /- Chemotherapy In Patients (Pts) With 1-3 Positive Nodes, Hormone Receptor (Hr)-Positive And Her2-Negative Breast Cancer With Recurrence Score (Rs) Of 25 Or Less: Swog S1007

A. M. Gonzalez-Angulo,W. E. Barlow,J. R. Gralow, F. Meric-Bernstam, D. F. Hayes,C. M. Moinpour,S. D. Ramsey,A. F. Schott, D. B. Sparks,K. S. Albain,G. N. Hortobagyi

CANCER RESEARCH（2011）

引用5浏览0引用

Predictors Of Recurrence Among Patients With Breast Cancer Who Achieved A Pathologic Complete Response (Pcr) After Neoadjuvant Systemic Chemotherapy

Mariana Chavez-MacGregor,Xiudong Lei,Jennifer K. Litton, A. Melhem,Elizabeth A. Mittendorf,Funda Meric-Bernstam,Aysegul A. Sahin,V. Valero,G. N. Hortobagyi,A. M. Gonzalez-Angulo

JOURNAL OF CLINICAL ONCOLOGY（2011）

引用0浏览0引用

Prevalence Of Brca1 And Brca2 Mutations In Women Diagnosed With Ductal Carcinoma In Situ

N. Elsayegh,S. Bayraktar, A. M. Gutierrez-Barrera, H. Lin, H. M. Kuerer, K. I. Muse, K. Ready,J. K. Litton, F. Meric-Bernstam,G. N. Hortobagyi, B. Arun

JOURNAL OF CLINICAL ONCOLOGY（2011）

引用0浏览0引用

Expression Of C-Met And Phospho C-Met In Breast Cancers By Subtype And Its Impact On Survival Outcomes